Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
复制标题
DOI:
10.1038/ncomms8557
复制
发表时间:
2015-07-03
影响因子:
16.6
通讯作者:
Takita J
中科院分区:
文献类型:
--
作者:
Seki M;Nishimura R;Yoshida K;Shimamura T;Shiraishi Y;Sato Y;Kato M;Chiba K;Tanaka H;Hoshino N;Nagae G;Shiozawa Y;Okuno Y;Hosoi H;Tanaka Y;Okita H;Miyachi M;Souzaki R;Taguchi T;Koh K;Hanada R;Kato K;Nomura Y;Akiyama M;Oka A;Igarashi T;Miyano S;Aburatani H;Hayashi Y;Ogawa S;Takita J
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Here we studied 60 RMSs using whole-exome/-transcriptome sequencing, copy number (CN) and DNA methylome analyses to unravel the genetic/epigenetic basis of RMS. On the basis of methylation patterns, RMS is clustered into four distinct subtypes, which exhibits remarkable correlation with mutation/CN profiles, histological phenotypes and clinical behaviours. A1 and A2 subtypes, especially A1, largely correspond to alveolar histology with frequent PAX3/7 fusions and alterations in cell cycle regulators. In contrast, mostly showing embryonal histology, both E1 and E2 subtypes are characterized by high frequency of CN alterations and/or allelic imbalances, FGFR4/RAS/AKT pathway mutations and PTEN mutations/methylation and in E2, also by p53 inactivation. Despite the better prognosis of embryonal RMS, patients in the E2 are likely to have a poor prognosis. Our results highlight the close relationships of the methylation status and gene mutations with the biological behaviour in RMS. Rhabdomyosarcoma is a common childhood soft-tissue cancer. Here Seki and Nishimura analyse the exome, transcriptome, copy number and DNA methylome of 60 sarcomas and identify distinct methylation subgroups associated with genetic and clinical features.